WGU D116 ADVANCED PHARMACOLOGY OA EXAM
2026/2027 Academic Year | Western Governors University
80 Questions | Verified Answers | 100% Correct | Graded A+
Core Domains
Pharmacokinetics & Pharmacodynamics | Autonomic Nervous System Drugs
Cardiovascular Pharmacology | Respiratory Pharmacology | GI Pharmacology
Endocrine & Hormonal Agents | Neuropharmacology | Psychotropic Medications
Antimicrobials | Oncology | Pain Management | Drug Interactions
, WGU D116 Advanced Pharmacology OA Exam
Abstract
This WGU D116 Advanced Pharmacology OA Exam evaluates competency in advanced pharmacology
for nurse practitioners through 80 multiple-choice questions. The examination covers
pharmacokinetics, autonomic drugs, cardiovascular and respiratory pharmacology, endocrine agents,
neuropharmacology, antimicrobials, oncology, pain management, and drug interactions. Each
question includes detailed rationale explaining drug mechanisms, therapeutic decisions, and clinical
applications essential for safe medication management in advanced practice.
Keywords: advanced pharmacology, pharmacokinetics, cardiovascular drugs, antimicrobials,
neuropharmacology, pain management, drug interactions, nurse practitioner
Introduction
The WGU D116 Advanced Pharmacology OA Exam assesses comprehensive knowledge of drug
therapy for advanced practice nurses. This examination measures competency in drug classifications,
mechanisms of action, therapeutic indications, contraindications, adverse effects, and clinical
decision-making essential for safe prescribing in advanced practice settings.
Examination Instructions
This examination consists of 80 multiple-choice questions. Select the single best answer for each
question. Questions appear in bold. Correct answers are shown in bold green. Rationales explaining
drug mechanisms and clinical decisions are provided in italics.
Examination Questions
1. The term 'first-pass metabolism' refers to:
A) Drug metabolism that occurs in the kidneys
B) Drug metabolism that occurs in the liver before the drug reaches systemic
circulation
C) The first dose of a medication
D) Metabolism that occurs only with intravenous administration
Rationale: First-pass metabolism occurs when orally administered drugs are absorbed from
the GI tract and pass through the portal circulation to the liver, where significant
metabolism may occur before the drug reaches systemic circulation, reducing
bioavailability.
2. A drug with a half-life of 12 hours will reach steady state in approximately:
A) 12 hours
B) 24 hours
C) 48-60 hours
D) 72-96 hours
Page 2 of 21
, WGU D116 Advanced Pharmacology OA Exam
Rationale: Steady state is reached after approximately 4-5 half-lives. With a 12-hour half-
life, steady state would be achieved in 48-60 hours (4-5 × 12 hours), which is clinically
important for timing therapeutic drug monitoring.
3. Which of the following statements about protein binding is correct?
A) Highly protein-bound drugs have a larger volume of distribution
B) Highly protein-bound drugs are more susceptible to drug interactions
C) Only unbound drug is pharmacologically inactive
D) Protein binding is constant and never changes
Rationale: Highly protein-bound drugs are susceptible to displacement interactions. When a
second drug competes for protein binding sites, the free concentration of the first drug
increases, potentially causing toxicity. Only unbound drug is pharmacologically active.
4. Cytochrome P450 3A4 is responsible for metabolizing approximately what
percentage of commonly used drugs?
A) 10%
B) 25%
C) 50%
D) 75%
Rationale: CYP3A4 is the most abundant CYP enzyme and metabolizes approximately 50%
of commonly prescribed medications. This makes it clinically significant for predicting drug
interactions and understanding individual variation in drug response.
5. A patient with severe renal impairment requires dose adjustment for a drug that is
80% renally eliminated. This adjustment is necessary because of changes in:
A) Absorption
B) Distribution
C) Metabolism
D) Elimination
Rationale: Drugs primarily eliminated by the kidneys will accumulate in renal impairment,
potentially leading to toxicity. Dosing adjustments based on creatinine clearance or eGFR
are essential for drugs with significant renal elimination.
6. The therapeutic index of a drug refers to:
A) The ratio between the toxic dose and the therapeutic dose
B) The number of patients who respond to treatment
C) The duration of drug action
D) The drug's bioavailability
Page 3 of 21
2026/2027 Academic Year | Western Governors University
80 Questions | Verified Answers | 100% Correct | Graded A+
Core Domains
Pharmacokinetics & Pharmacodynamics | Autonomic Nervous System Drugs
Cardiovascular Pharmacology | Respiratory Pharmacology | GI Pharmacology
Endocrine & Hormonal Agents | Neuropharmacology | Psychotropic Medications
Antimicrobials | Oncology | Pain Management | Drug Interactions
, WGU D116 Advanced Pharmacology OA Exam
Abstract
This WGU D116 Advanced Pharmacology OA Exam evaluates competency in advanced pharmacology
for nurse practitioners through 80 multiple-choice questions. The examination covers
pharmacokinetics, autonomic drugs, cardiovascular and respiratory pharmacology, endocrine agents,
neuropharmacology, antimicrobials, oncology, pain management, and drug interactions. Each
question includes detailed rationale explaining drug mechanisms, therapeutic decisions, and clinical
applications essential for safe medication management in advanced practice.
Keywords: advanced pharmacology, pharmacokinetics, cardiovascular drugs, antimicrobials,
neuropharmacology, pain management, drug interactions, nurse practitioner
Introduction
The WGU D116 Advanced Pharmacology OA Exam assesses comprehensive knowledge of drug
therapy for advanced practice nurses. This examination measures competency in drug classifications,
mechanisms of action, therapeutic indications, contraindications, adverse effects, and clinical
decision-making essential for safe prescribing in advanced practice settings.
Examination Instructions
This examination consists of 80 multiple-choice questions. Select the single best answer for each
question. Questions appear in bold. Correct answers are shown in bold green. Rationales explaining
drug mechanisms and clinical decisions are provided in italics.
Examination Questions
1. The term 'first-pass metabolism' refers to:
A) Drug metabolism that occurs in the kidneys
B) Drug metabolism that occurs in the liver before the drug reaches systemic
circulation
C) The first dose of a medication
D) Metabolism that occurs only with intravenous administration
Rationale: First-pass metabolism occurs when orally administered drugs are absorbed from
the GI tract and pass through the portal circulation to the liver, where significant
metabolism may occur before the drug reaches systemic circulation, reducing
bioavailability.
2. A drug with a half-life of 12 hours will reach steady state in approximately:
A) 12 hours
B) 24 hours
C) 48-60 hours
D) 72-96 hours
Page 2 of 21
, WGU D116 Advanced Pharmacology OA Exam
Rationale: Steady state is reached after approximately 4-5 half-lives. With a 12-hour half-
life, steady state would be achieved in 48-60 hours (4-5 × 12 hours), which is clinically
important for timing therapeutic drug monitoring.
3. Which of the following statements about protein binding is correct?
A) Highly protein-bound drugs have a larger volume of distribution
B) Highly protein-bound drugs are more susceptible to drug interactions
C) Only unbound drug is pharmacologically inactive
D) Protein binding is constant and never changes
Rationale: Highly protein-bound drugs are susceptible to displacement interactions. When a
second drug competes for protein binding sites, the free concentration of the first drug
increases, potentially causing toxicity. Only unbound drug is pharmacologically active.
4. Cytochrome P450 3A4 is responsible for metabolizing approximately what
percentage of commonly used drugs?
A) 10%
B) 25%
C) 50%
D) 75%
Rationale: CYP3A4 is the most abundant CYP enzyme and metabolizes approximately 50%
of commonly prescribed medications. This makes it clinically significant for predicting drug
interactions and understanding individual variation in drug response.
5. A patient with severe renal impairment requires dose adjustment for a drug that is
80% renally eliminated. This adjustment is necessary because of changes in:
A) Absorption
B) Distribution
C) Metabolism
D) Elimination
Rationale: Drugs primarily eliminated by the kidneys will accumulate in renal impairment,
potentially leading to toxicity. Dosing adjustments based on creatinine clearance or eGFR
are essential for drugs with significant renal elimination.
6. The therapeutic index of a drug refers to:
A) The ratio between the toxic dose and the therapeutic dose
B) The number of patients who respond to treatment
C) The duration of drug action
D) The drug's bioavailability
Page 3 of 21
